Modulation of the immune response by Middle East respiratory syndrome coronavirus

Journal of Cellular Physiology

Volumn 234, Issue 3, 2019, Pages 2143-2151

  Shokri, Somayeh ^a   Mahmoudvand, Shahab ^a   Taherkhani, Reza ^b   Farshadpour, Fatemeh ^b  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

immune evasion; immune response; Middle East respiratory syndrome coronavirus

Indexed keywords

DOUBLE STRANDED RNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERLEUKIN 10; M PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NONSTRUCTURAL PROTEIN 15; NONSTRUCTURAL PROTEIN 4A; NONSTRUCTURAL PROTEIN 4B; PAPAIN; PAPAIN LIKE PROTEASE UBIQUITIN LIKE DOMAIN; UNCLASSIFIED DRUG; VIRAL PROTEIN; VIRUS RNA;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; APOPTOSIS; CELL PROLIFERATION; CYTOKINE RELEASE; CYTOKINE RESPONSE; DOWN REGULATION; HOST RESISTANCE; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; IMMUNOMODULATION; INNATE IMMUNITY; MACROPHAGE; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MYELOID PROGENITOR CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; CORONAVIRUS INFECTION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; PATHOGENICITY; PATHOLOGY; VIROLOGY;

CORONAVIRUS INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS;

EID: 85052378077     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.27155     Document Type: Review

References (77)

1. Al Hajjar, S., Memish, Z. A., & Mcintosh, K. (2013). Middle East respiratory syndrome coronavirus (MERS-CoV): A perpetual challenge. Annals of Saudi Medicine, 33(5), 427–436.
2. Alcami, A., & Koszinowski, U. H. (2000). Viral mechanisms of immune evasion. Immunology Today, 21(9), 447–455.
3. Almazan, F., DeDiego, M. L., Sola, I., Zuniga, S., Nieto-Torres, J. L., Marquez-Jurado, S., … Enjuanes, L. (2013). Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate. mBio, 4(5), e00650–00613.
4. Al-Tawfiq, J., & Memish, Z. (2016). The middle east respiratory syndrome coronavirus respiratory infection: An emerging infection from the Arabian Peninsula, The Microbiology of Respiratory System Infections (pp. 55–63). Elsevier.
5. Bosch, B. J., Raj, V. S., & Haagmans, B. L. (2013). Spiking the MERS-coronavirus receptor. Cell Research, 23(9), 1069–1070.
6. Broxmeyer, H. E., Sherry, B., Cooper, S., Lu, L., Maze, R., Beckmann, M. P., … Ralph, P. (1993). Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression. The Journal of Immunology, 150(8), 3448–3458.
7. Chan, J. F.-W., Lau, S. K.-P., & Woo, P. C.-Y. (2013). The emerging novel Middle East respiratory syndrome coronavirus: The “knowns” and “unknowns”. Journal of the Formosan Medical Association, 112(7), 372–381.
8. Chen, X., Chughtai, A. A., Dyda, A., & MacIntyre, C. R. (2017). Comparative epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia and South Korea. Emerging Microbes & Infections, 6(6), e51.
9. Cho, C.-C., Lin, M.-H., Chuang, C.-Y., & Hsu, C.-H. (2016). Macro domain from Middle East respiratory syndrome coronavirus (MERS-CoV) is an efficient ADP-ribose binding module crystal structure and biochemical studies. Journal of Biological Chemistry, 291(10), 4894–4902.
10. Chu, H., Zhou, J., Ho-Yin Wong, B., Li, C., Cheng, Z.-S., Lin, X., … Yuen, K.-Y. (2014). Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response. Virology, 454-455, 197–205. [Supplement C].
11. Chu, H., Zhou, J., Wong, B. H.-Y., Li, C., Chan, J. F.-W., Cheng, Z.-S., … Yuen, K. Y. (2015). Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. The Journal of Infectious Diseases, 213(6), 904–914.
12. Clementz, M. A., Chen, Z., Banach, B. S., Wang, Y., Sun, L., Ratia, K., … Baker, S. C. (2010). Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. Journal of Virology, 84(9), 4619–4629.
13. Coleman, C. M., Sisk, J. M., Mingo, R. M., Nelson, E. A., White, J. M., & Frieman, M. B. (2016). Abelson kinase inhibitors are potent inhibitors of severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus fusion. Journal of Virology, 90(19), 8924–8933.
14. Corman, V. M., Ithete, N. L., Richards, L. R., Schoeman, M. C., Preiser, W., Drosten, C., & Drexler, J. F. (2014). Rooting the phylogenetic tree of Middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat. Journal of Virology, 88(19), 11297–11303.
15. Deng, X., Hackbart, M., Mettelman, R. C., O’Brien, A., Mielech, A. M., Yi, G., … Baker, S. C. (2017). Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages. Proceedings of the National Academy of Sciences, 114(21), E4251–E4260.
16. Drosten, C., Seilmaier, M., Corman, V. M., Hartmann, W., Scheible, G., Sack, S., … Wendtner, C. M. (2013). Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. The Lancet Infectious Diseases, 13(9), 745–751.
17. Durai, P., Batool, M., Shah, M., & Choi, S. (2015). Middle East respiratory syndrome coronavirus: Transmission, virology and therapeutic targeting to aid in outbreak control. Experimental & Molecular Medicine, 47(8), e181.
18. Faure, E., Poissy, J., Goffard, A., Fournier, C., Kipnis, E., Titecat, M., … Guery, B. (2014). Distinct immune response in two MERS-CoV-infected patients: Can we go from bench to bedside? PLoS One, 9(2), e88716.
19. Ferran, M. C., & Skuse, G. R. (2017). Evasion of host innate immunity by emerging viruses: Antagonizing host RIG-I pathways. J Emerg Dis Virol, 3(3).
20. Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., … Maniatis, T. (2003). IKKε and TBK1 are essential components of the IRF3 signaling pathway. Nature Immunology, 4(5), 491–496.
21. González-Navajas, J. M., Lee, J., David, M., & Raz, E. (2012). Immunomodulatory functions of type I interferons. Nature Reviews Immunology, 12(2), 125–135.
22. Goubau, D., Deddouche, S., & Reis e Sousa, C. (2013). Cytosolic sensing of viruses. Immunity, 38(5), 855–869.
23. de Groot, R. J., Baker, S. C., Baric, R. S., Brown, C. S., Drosten, C., Enjuanes, L., … Ziebuhr, J. (2013). Middle East respiratory syndrome coronavirus (MERS-CoV): Announcement of the coronavirus study group. Journal of Virology, 87(14), 7790–7792.
24. Guo, B., & Cheng, G. (2007). Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK. Journal of Biological Chemistry, 282(16), 11817–11826.
25. Haagmans, B. L., Kuiken, T., Martina, B. E., Fouchier, R. A. M., Rimmelzwaan, G. F., Van Amerongen, G., … Osterhaus, A. D. M. E. (2004). Pegylated interferon-α protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nature Medicine, 10(3), 290–293.
26. de Haan, C. A. M., Masters, P. S., Shen, X., Weiss, S., & Rottier, P. J. M. (2002). The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host. Virology, 296(1), 177–189.
27. Haijema, B. J., Volders, H., & Rottier, P. J. M. (2004). Live, attenuated coronavirus vaccines through the directed deletion of group-specific genes provide protection against feline infectious peritonitis. Journal of Virology, 78(8), 3863–3871.
28. Hiscott, J. (2007). Triggering the innate antiviral response through IRF-3 activation. Journal of Biological Chemistry, 282(21), 15325–15329.
29. Josset, L., Menachery, V. D., Gralinski, L. E., Agnihothram, S., Sova, P., Carter, V. S., … Katze, M. G. (2013). Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus. mBio, 4(3), e00165–00113.
30. Kanwar, A., Selvaraju, S., & Esper, F. (2017). Human coronavirus-HKU1 infection among adults in Cleveland, Ohio. Open Forum Infectious Diseases, 4(2), ofx052.
31. Karin, M. (2006). Nuclear factor-κB in cancer development and progression. Nature, 441(7092), 431–436.
32. Kato, H., Takahasi, K., & Fujita, T. (2011). RIG-I-like receptors: Cytoplasmic sensors for non-self RNA. Immunological Reviews, 243(1), 91–98.
33. Kim, E. S., Choe, P. G., Park, W. B., Oh, H. S., Kim, E. J., Nam, E. Y., … Oh, M. (2016). Clinical progression and cytokine profiles of Middle East respiratory syndrome coronavirus infection. Journal of Korean Medical Science, 31(11), 1717–1725.
34. Kindler, E., & Thiel, V. (2014). To sense or not to sense viral RNA—Essentials of coronavirus innate immune evasion. Current Opinion in Microbiology, 20, 69–75. [Supplement C].
35. Kok, K.-H., Lui, P.-Y., Ng, M. H., Siu, K.-L., Au, S. W., & Jin, D.-Y. (2011). The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response. Cell Host and Microbe, 9(4), 299–309.
36. Lau, S. K., Li, K. S., Tsang, A. K., Lam, C. S., Ahmed, S., Chen, H., … Yuen, K.-Y. (2013). Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: Implications for the origin of the novel Middle East respiratory syndrome coronavirus. Journal of Virology, 87(15), 8638–8650.
37. Lee, H.-R., Lee, S., Chaudhary, P. M., Gill, P., & Jung, J. U. (2010). Immune evasion by Kaposi’s sarcoma-associated herpesvirus. Future Microbiology, 5(9), 1349–1365.
38. Liu, D. X., Fung, T. S., Chong, K. K.-L., Shukla, A., & Hilgenfeld, R. (2014). Accessory proteins of SARS-CoV and other coronaviruses. Antiviral Research, 109, 97–109. [Supplement C].
39. Liu, T., Zhang, L., Joo, D., & Sun, S.-C. (2017). NF-κB signaling in inflammation. Signal Transduction and Targeted Therapy, 2, 17023.
40. Lu, G., Hu, Y., Wang, Q., Qi, J., Gao, F., Li, Y., … Gao, G. F. (2013). Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature, 500(7461), 227–231.
41. Lui, P.-Y., Wong, L. Y., Fung, C.-L., Siu, K.-L., Yeung, M.-L., Yuen, K.-S., … Jin, D.-Y. (2016). Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3. Emerging Microbes & Infections, 5(4), e39.
42. Matthews, K. L., Coleman, C. M., van der Meer, Y., Snijder, E. J., & Frieman, M. B. (2014). The ORF4b-encoded accessory proteins of Middle East respiratory syndrome coronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signalling. The Journal of General Virology, 95(Pt 4), 874–882.
43. Mielech, A. M., Kilianski, A., Baez-Santos, Y. M., Mesecar, A. D., & Baker, S. C. (2014). MERS-CoV papain-like protease has deISGylating and deubiquitinating activities. Virology, 450-451, 64–70.
44. Mou, H., Raj, V. S., van Kuppeveld, F. J., Rottier, P. J., Haagmans, B. L., & Bosch, B. J. (2013). The receptor binding domain of the new MERS coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies. Journal of Virology, 87, 01277–01213.
45. Mustafa, S., Balkhy, H., & Gabere, M. N. (2017). Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): A review. Journal of Infection and Public Health, 11, 9–17.
46. Neuman, B. W., Kiss, G., Kunding, A. H., Bhella, D., Baksh, M. F., Connelly, S., … Buchmeier, M. J. (2011). A structural analysis of M protein in coronavirus assembly and morphology. Journal of Structural Biology, 174(1), 11–22.
47. Nicholson, L. B. (2016). The immune system. Essays in Biochemistry, 60(3), 275–301.
48. Niemeyer, D., Zillinger, T., Muth, D., Zielecki, F., Horvath, G., Suliman, T., … Muller, M. A. (2013). Middle East respiratory syndrome coronavirus accessory protein 4a Is a Type I interferon antagonist. Journal of Virology, 87(22), 12489–12495.
49. Ohnuma, K., Haagmans, B. L., Hatano, R., Raj, V. S., Mou, H., Iwata, S., … Morimoto, C. (2013). Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody. Journal of Virology, 87(24), 13892–13899.
50. Organization, W. H. (2017). Middle East respiratory syndrome coronavirus (MERS-CoV)–Saudi Arabia, Geneva: WHO. Accessed 21 July 2017. Available at http://wwwwhoint/emergencies/mers-cov/en/
51. Pfeffer, L. M. (2011). The Role of nuclear factor κB in the interferon response. Journal of Interferon & Cytokine Research, 31(7), 553–559.
52. Rabouw, H. H., Langereis, M. A., Knaap, R. C. M., Dalebout, T. J., Canton, J., Sola, I., … van Kuppeveld, F. J. M. (2016). Middle East respiratory coronavirus accessory protein 4a inhibits PKR-mediated antiviral stress responses. PLoS Pathogens, 12(10), e1005982.
53. Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., … Haagmans, B. L. (2013). Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature, 495(7440), 251–254.
54. Raj, V. S., Smits, S. L., Provacia, L. B., van den Brand, J. M. A., Wiersma, L., Ouwendijk, W. J. D., … Haagmans, B. L. (2014). Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus. Journal of Virology, 88(3), 1834–1838.
55. Seth, R. B., Sun, L., Ea, C.-K., & Chen, Z. J. (2005). Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF3. Cell, 122(5), 669–682.
56. Simmons, R. A., Willberg, C. B., & Paul, K. (2001). Immune evasion by viruses. eLS. John Wiley & Sons, Ltd.
57. Siu, K.-L., Chan, C.-P., Kok, K.-H., Chiu-Yat Woo, P., & Jin, D.-Y. (2014). Suppression of innate antiviral response by severe acute respiratory syndrome coronavirus M protein is mediated through the first transmembrane domain. Cellular and Molecular Immunology, 11(2), 141–149.
58. Siu, K.-L., Kok, K.-H., Ng, M.-H. J., Poon, V. K. M., Yuen, K.-Y., Zheng, B.-J., & Jin, D.-Y. (2009). Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3·TANK·TBK1/IKKϵ Complex. The Journal of Biological Chemistry, 284(24), 16202–16209.
59. Siu, K.-L., Yeung, M. L., Kok, K.-H., Yuen, K.-S., Kew, C., Lui, P.-Y., … Jin, D.-Y. (2014). Middle East respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response. Journal of Virology, 88(9), 4866–4876.
60. Suhara, W., Yoneyama, M., Kitabayashi, I., & Fujita, T. (2002). Direct involvement of CREB-binding protein/p300 in sequence-specific DNA binding of virus-activated interferon regulatory factor-3 holocomplex. Journal of Biological Chemistry, 277(25), 22304–22313.
61. Sumpter, R., Loo, Y.-M., Foy, E., Li, K., Yoneyama, M., Fujita, T., … Gale, M. (2005). Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. Journal of Virology, 79(5), 2689–2699.
62. Takeuchi, O., & Akira, S. (2009). Innate immunity to virus infection. Immunological Reviews, 227(1), 75–86.
63. Thornbrough, J. M., Jha, B. K., Yount, B., Goldstein, S. A., Li, Y., Elliott, R., … Weiss, S. R. (2016). Middle East respiratory syndrome coronavirus NS4b protein inhibits host RNase L activation. mBio, 7(2), e00258–00216.
64. Totura, A. L., & Baric, R. S. (2012). SARS coronavirus pathogenesis: Host innate immune responses and viral antagonism of interferon. Current Opinion in Virology, 2(3), 264–275.
65. De Veer, M. J., Holko, M., Frevel, M., Walker, E., Der, S., Paranjape, J. M., … Williams, B. R. (2001). Functional classification of interferon-stimulated genes identified using microarrays. Journal of Leukocyte Biology, 69(6), 912–920.
66. Vossen, M., Westerhout, E., Söderberg-Nauclér, C., & Wiertz, E. (2002). Viral immune evasion: A masterpiece of evolution. Immunogenetics, 54(8), 527–542.
67. Wong, L.-Y. R., Lui, P.-Y., & Jin, D.-Y. (2016). A molecular arms race between host innate antiviral response and emerging human coronaviruses. Virologica Sinica, 31(1), 12–23.
68. Yang, X., Chen, X., Bian, G., Tu, J., Xing, Y., Wang, Y., & Chen, Z. (2014). Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease. Journal of General Virology, 95(3), 614–626.
69. Yang, Y., Zhang, L., Geng, H., Deng, Y., Huang, B., Guo, Y., … Tan, W. (2013). The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists. Protein & Cell, 4(12), 951–961.
70. Ying, T., Li, W., & Dimitrov, D. S. (2016). Discovery of T-cell infection and apoptosis by Middle East respiratory syndrome coronavirus. The Journal of Infectious Diseases, 213(6), 877–879.
71. Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., … Fujita, T. (2004). The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nature Immunology, 5(7), 730–737.
72. Zhang, N., Jiang, S., & Du, L. (2014). Current advancements and potential strategies in the development of MERS-CoV vaccines. Expert Review of Vaccines, 13(6), 761–774.
73. Zhao, J., Li, K., Wohlford-Lenane, C., Agnihothram, S. S., Fett, C., Zhao, J., … Perlman, S. (2014). Rapid generation of a mouse model for Middle East respiratory syndrome. Proceedings of the National Academy of Sciences of the United States of America, 111(13), 4970–4975.
74. Zhao, L., Jha, B. K., Wu, A., Elliott, R., Ziebuhr, J., Gorbalenya, A. E., … Weiss, S. R. (2012). Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology. Cell Host and Microbe, 11(6), 607–616.
75. Zhou, J., Chu, H., Chan, J. F.-W., & Yuen, K.-Y. (2015). Middle East respiratory syndrome coronavirus infection: Virus-host cell interactions and implications on pathogenesis. Virology Journal, 12(1), 218.
76. Zhou, J., Chu, H., Li, C., Wong, B. H.-Y., Cheng, Z.-S., Poon, V. K.-M., … Yuen, K.-Y. (2014). Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: Implications for pathogenesis. The Journal of Infectious Diseases, 209(9), 1331–1342.
77. Zumla, A., Hui, D. S., & Perlman, S. (2015). Middle East respiratory syndrome. The Lancet, 386(9997), 995–1007.